Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Alembic Pharma bags USFDA nod for Arformoterol Tartrate Inhalation Solution

Ruchika Sharma11 May 2022 1:24 PM IST

This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies Private Limited.

USFDA issues 6 observations after inspection of Aurobindo Pharma's Jedcherla facility

Ruchika Sharma11 May 2022 12:59 PM IST

"The Company will respond to the USFDA within the stipulated timeline and work closely with USFDA to close the observations," the company added.

Strides, Incepta partner to expand women health access with WHO prequalified contraceptive

Bharat Biotech, CEPI collaborate to develop 'variant-proof' COVID vaccine

Ruchika Sharma11 May 2022 12:24 PM IST

CEPI will fund the researchers to conduct activities including immunogen design, preclinical studies, manufacturing process development and a Phase 1...

Novavax 2022 COVID vaccine deliveries off to slow start, shares drop

Ruchika Sharma11 May 2022 9:00 AM IST

New Delhi: Novavax Inc on Monday revealed a sharp drop in first-quarter COVID-19 research funding and said it shipped less than a fourth of the total...

Healthcare recruitment platform Jobizo raises USD 1.4 million in pre-Series A funding

Dr Agarwal's Health Care raises over 1000 crore funding from TPG Growth, Temasek

Ruchika Sharma11 May 2022 9:00 AM IST

New Delhi: Chennai-based Dr. Agarwal's Health Care Ltd. (DAHCL) has closed a fund raise of ₹1,050 crore from TPG Growth, the middle market and...

Cipla introduces 'RT-Direct' multiplex COVID-19 RT PCR Test kit in India

Ruchika Sharma10 May 2022 4:37 PM IST

RT-Direct test protocol does not require any RNA extraction process, making it faster and helps deliver results in just 45 minutes.

Abbott unveils HBsAg Next Assay in India for Hepatitis B detection

Ruchika Sharma10 May 2022 3:41 PM IST

With the HBsAg Next Qualitative Solution, laboratories can now better detect, analyze the infection and reduce the risks of undetected virus, have a...

Granules India gets USFDA EIR for Bonthapally facility

Sun Pharma gets 10 USFDA observations for Halol facility

Ruchika Sharma10 May 2022 1:04 PM IST

Mumbai: Pharma major, Sun Pharma, today announced that US Food and Drug Administration (USFDA) has recently concluded the Good Manufacturing...

Ex Dr Reddys President Saumen Chakraborty joins Premas Biotech Board of Directors

Ruchika Sharma10 May 2022 11:30 AM IST

Saumen Chakraborty retired as the President and Chief Financial Officer of Dr Reddy’s in 2020 and served as an Advisor to them for the next year.

COVID vaccine makers shift focus to booster shots

Ruchika Sharma10 May 2022 11:00 AM IST

Pfizer Chief Executive Albert Bourla said in an interview that adults who are still unvaccinated are unlikely to seek out shots now, more than two...

India says no to UK data exclusivity demand to protect generic drug firms

Myovant Sciences, Accord Healthcare ink pact for prostate cancer treatment Relugolix

Ruchika Sharma10 May 2022 10:15 AM IST

ORGOVYX (relugolix, 120 mg) is indicated in Europe for the treatment of adult patients with advanced hormone-sensitive prostate cancer.

BioNTech posts tripled Q1 vaccine sales but still flags full-year decline

Ruchika Sharma10 May 2022 9:15 AM IST

BioNTech reiterated its 2022 vaccine revenue guidance of between 13 billion and 17 billion euros, down from 19 billion last year, implying a decline...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok